New York State Common Retirement Fund Vertex Pharmaceuticals Inc Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 308,577 shares of VRTX stock, worth $134 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
308,577
Previous 340,272
9.31%
Holding current value
$134 Million
Previous $151 Million
20.22%
% of portfolio
0.16%
Previous 0.21%
Shares
45 transactions
Others Institutions Holding VRTX
# of Institutions
1,820Shares Held
231MCall Options Held
1.83MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA25.9MShares$11.2 Billion1.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$10.5 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.6MShares$7.18 Billion1.27% of portfolio
-
State Street Corp Boston, MA11.6MShares$5.04 Billion0.16% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $111B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...